Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
3.200
+0.410 (14.70%)
At close: Aug 28, 2026, 4:00 PM EDT
3.299
+0.099 (3.09%)
After-hours: Aug 28, 2026, 7:58 PM EDT
Femasys Revenue
Femasys had revenue of $331.83K in the quarter ending June 30, 2026, a decrease of -18.92%. This brings the company's revenue in the last twelve months to $2.30M, up 21.86% year-over-year. In the year 2025, Femasys had annual revenue of $2.29M with 40.77% growth.
Revenue (ttm)
$2.30M
Revenue Growth
+21.86%
P/S Ratio
11.65
Revenue / Employee
$42,583
Employees
54
Market Cap
26.80M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.29M | 664.21K | 40.77% |
| Dec 31, 2024 | 1.63M | 557.14K | 51.97% |
| Dec 31, 2023 | 1.07M | -134.25K | -11.13% |
| Dec 31, 2022 | 1.21M | 26.53K | 2.25% |
| Dec 31, 2021 | 1.18M | 141.77K | 13.66% |
| Dec 31, 2020 | 1.04M | 108.85K | 11.72% |
| Dec 31, 2019 | 929.06K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.81M |
| Retractable Technologies | 33.90M |
| Bionano Genomics | 30.18M |
| Precision Optics Corporation | 28.94M |
| Nephros | 20.72M |
| Milestone Scientific | 9.42M |
| Lucyd | 3.41M |
| Zentek | 76.23K |
FEMY News
- 3 days ago - Femasys announces fertility partnership with UNC Health - TheFly
- 3 days ago - Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations - GlobeNewsWire
- 10 days ago - Femasys announces FDA approval of FemBloc modular premarket approval application - TheFly
- 11 days ago - Femasys price target lowered to $10 from $30 at Lake Street - TheFly
- 12 days ago - Femasys issued patent for FemBloc blended polymer component - TheFly
- 13 days ago - Femasys price target lowered to $10 from $30 at Maxim - TheFly
- 14 days ago - Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update - GlobeNewsWire
- 15 days ago - Femasys Earnings release: Q2 2026 - Filings